Single Use Consumables Market Size, Share & Trends by Product (Tubing, Connectors, Disconnectors, Adapters, Valves, Capsule Filter, Sensors), Application (Filtration, Storage, Cell Culture, Sampling), End User (Biotech, Pharma, CROs & CMOs, OEMs) – Global Forecast to 2027
The global single-use consumables market is undergoing a rapid transformation, fueled by the expanding biopharmaceutical sector and the increasing shift toward single-use technologies (SUTs). According to recent industry insights, the market — valued at $2.2 billion in 2022 — is projected to reach $4.7 billion by 2027, growing at a CAGR of 16.6% from 2022 to 2027.
This surge reflects a significant change in how the pharmaceutical and biopharmaceutical industries approach manufacturing — prioritizing flexibility, cost efficiency, and reduced contamination risks.
Download PDF Brochure:
http://www.marketsandmarkets.com/pdfdown…d=44374840
🔬 What’s Driving the Growth?
* Lower Operational Costs and Increased Productivity
Single-use consumables are transforming production processes. Traditional bioprocessing required time-intensive cleaning (CIP) and sterilization (SIP) procedures to avoid cross-contamination — increasing cost and complexity.
Single-use technologies eliminate these steps, delivering direct savings on labor, materials, and capital investment.
Facilities using single-use systems require up to 40% lower initial investments compared to traditional stainless-steel systems. These cost efficiencies, combined with faster changeovers and reduced downtime, are driving wider adoption across the biopharmaceutical industry.
⚠️ Market Challenge: Extractables and Leachables
While the benefits are clear, one technical challenge persists — extractables and leachables (E&L).
These are substances that can migrate from single-use materials into drug formulations, potentially impacting product safety.
Although no universal standards yet exist, organizations like the
Bio-Process Systems Alliance (BPSA) are developing testing protocols to minimize such risks.
Continued innovation in material science and regulatory collaboration will be key to addressing this restraint effectively.
🌏 Emerging Markets: The Next Frontier
The Asia Pacific region is rapidly emerging as a growth hotspot. Countries such as China, India, South Korea, Singapore, and Vietnam are attracting significant investment in biopharmaceutical manufacturing infrastructure.
For example, Merck announced a $110 million investment in expanding its Mobius Single-Use Manufacturing Center in Wuxi, China — underscoring the region’s strategic role in the global single-use consumables supply chain.
These emerging economies offer immense potential for suppliers that face stringent regulatory barriers in Western markets.
🧬 Key Market Segment Insights
End Users:
* Biopharmaceutical & Pharmaceutical Companies dominate the market, leveraging single-use consumables for vaccine production and aseptic manufacturing.
* CROs and CMOs are also increasing their adoption, driven by contract-based research and flexible production needs.
* Academic & Research Institutes represent a growing niche segment with increasing R&D in biologics.
Applications Include:
* Filtration
* Cell Culture & Mixing
* Storage
* Sampling
Key Products:
* Tubings
* Connectors & Disconnectors
* Adapters & Valves
* Disposable Capsule Filters
* Single-use Sensors
🌎 Regional Analysis
North America:
* Largest market share in 2022, led by major players such as Danaher Corporation (US) and Thermo Fisher Scientific (US).
* Growth is supported by high demand for biologics and strong biomanufacturing infrastructure.
Europe:
* Focused on advanced biologics and sustainability-driven single-use solutions.
Asia Pacific:
* Expected to register the fastest growth due to expanding local biopharma production, increasing biosimilar adoption, and government-backed R&D investments.
Request Sample Pages:
http://www.marketsandmarkets.com/request…d=44374840
🏭 Key Industry Players
* Thermo Fisher Scientific, Inc. (US)
* Sartorius Stedim Biotech (France)
* Danaher Corporation (US)
* Merck KGaA (Germany)
* Avantor Inc. (US)
* CPC (Colder Products Company)
* Cytiva (US)
🚀 Recent Industry Developments
* September 2021: CPC launched the first aseptic connectors designed to simplify tubing connections in small-format assemblies.
* September 2021: Cytiva, in partnership with Wego Pharmaceutical Co. Ltd., expanded its manufacturing capacity in Asia Pacific, tripling the region’s single-use consumables supply capability.
💡 Market Outlook
The rise of biologics, gene therapies, and vaccines has permanently altered the landscape of pharmaceutical manufacturing. Single-use consumables are now seen as essential enablers of agile, contamination-free, and cost-efficient production systems.
With robust growth projected and increasing investments in emerging economies, the next five years promise to be transformative for this market.
✅ Conclusion
The single-use consumables market is at the heart of the next evolution in bioprocessing — enabling flexible, faster, and cleaner manufacturing.
As leading players innovate and emerging markets scale up production, the industry’s future will be defined by sustainability, standardization, and strategic global expansion.
News From
MarketsandMarkets™
Category: Industry Reports & Market Analysis Profile: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, w …
This email address is being protected from spambots. You need JavaScript enabled to view it.
